Tackling Antimicrobial Resistance in the Shadow of COVID-19
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is a challenge for ongoing efforts to combat antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 disease and drug stewardship evolves, there is likely to be a lasting impact of increased use of antimicrobial ag...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2021-08-01
|
| Series: | mBio |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/mBio.00473-21 |